Primary osteoporosis is bone loss that comes from aging and, in women, the fall in estrogen after menopause, rather than from another disease or a medication. It weakens the internal structure of bone until a minor fall or even a cough can cause a fracture. Doctors diagnose it with a bone density scan and treat it with lifestyle measures and, for many people, medication that slows bone loss or builds new bone.
In my practice, the key question with any new osteoporosis diagnosis is whether it is truly primary or whether something else is driving it. This article explains what makes osteoporosis “primary,” its two main types, how it is diagnosed, and how treatment works. For the wider picture, see our complete osteoporosis guide.
What Is Primary Osteoporosis?
Osteoporosis means “porous bone.” Healthy bone is constantly remodeled: osteoclasts dissolve old bone and osteoblasts lay down new bone. In osteoporosis, breakdown outpaces formation. Bone mass falls, and the fine internal struts of spongy bone become thinner and disconnected.
Osteoporosis is called primary when no underlying cause is found. It is called secondary when another condition or drug is responsible. Common secondary causes include long-term glucocorticoid (steroid) use, an overactive thyroid or parathyroid, celiac disease, and multiple myeloma. Telling the two apart matters, because treating a secondary cause can halt the bone loss at its source.
| Feature | Primary osteoporosis | Secondary osteoporosis |
|---|---|---|
| Cause | Aging and menopause-related estrogen loss | An identifiable disease or medication |
| Typical patient | Postmenopausal women, older men and women | Any age, including younger adults and men |
| Key step in workup | Rule out secondary causes | Identify and treat the underlying driver |
| Examples | Postmenopausal (Type I), age-related (Type II) | Steroid-induced, hyperparathyroidism, myeloma-related |
The Two Types of Primary Osteoporosis
Type I: Postmenopausal Osteoporosis
Estrogen normally restrains osteoclasts. After menopause, estrogen falls sharply, osteoclast activity rises, and bone loss speeds up for several years. Trabecular (spongy) bone is affected first, so vertebral fractures and wrist (distal radius) fractures are typical. Onset is usually within the first one to two decades after menopause.
Type II: Age-Related (Senile) Osteoporosis
Type II usually appears after about age 70 and affects both men and women, though women remain more often affected. It reflects slower osteoblast activity, less efficient calcium absorption and lower vitamin D production in older skin. Both cortical and trabecular bone thin, which is why hip fractures become prominent. Our dedicated article on senile osteoporosis covers this type in depth.
Risk Factors and Symptoms
Bone mass peaks in early adulthood, roughly in the late twenties to early thirties, and then gradually declines. The higher your peak, the more reserve you have. Risk factors for primary osteoporosis include:
- Female sex and early or surgical menopause
- Older age
- Family history, especially a parent who fractured a hip
- Low body weight or small frame
- Low calcium and vitamin D intake
- Smoking, excess alcohol and physical inactivity
Genetics strongly shape peak bone mass, and variants in genes involved in collagen and bone signaling, such as COL1A1 and LRP5, have been linked to bone density.
Primary osteoporosis causes no symptoms until a fracture occurs. Warning signs include loss of height, a forward-curving upper back (kyphosis), sudden back pain from a vertebral compression fracture, or a fracture from a fall at standing height or less. Such a fracture is called a fragility fracture.
How Primary Osteoporosis Is Diagnosed
The standard test is a dual-energy X-ray absorptiometry (DXA) scan of the hip and lumbar spine. The result is expressed as a T-score, which compares your bone density with that of a healthy young adult.
| T-score | Interpretation |
|---|---|
| −1.0 or higher | Normal bone density |
| Between −1.0 and −2.5 | Osteopenia (low bone mass) |
| −2.5 or lower | Osteoporosis |
| −2.5 or lower plus a fragility fracture | Severe (established) osteoporosis |
A fragility fracture of the hip or spine can establish the diagnosis even when the T-score is above −2.5. Doctors often combine bone density with a fracture risk calculator such as FRAX to estimate 10-year risk and guide treatment decisions.
To confirm the osteoporosis is primary, blood tests usually check calcium, phosphate, kidney and liver function, vitamin D, thyroid function and parathyroid hormone. Where appropriate, doctors also run a blood count and protein studies to exclude myeloma. Bone turnover markers such as CTX and P1NP can help monitor response to treatment.
Treatment and Management
Lifestyle Foundations
- Calcium: about 1,000–1,200 mg per day, ideally mostly from food
- Vitamin D: commonly 800–1,000 IU per day for older adults, adjusted to blood levels
- Exercise: weight-bearing, resistance and balance training
- Stopping smoking, limiting alcohol and making the home safer to prevent falls
Medications
- Bisphosphonates (alendronate, risedronate, zoledronic acid) slow osteoclast activity and are usually first-line.
- Denosumab, an antibody against RANKL, is given by injection every six months. It should not be stopped abruptly without a plan, because bone loss can rebound.
- Raloxifene, a selective estrogen receptor modulator, is an option for some postmenopausal women.
- Anabolic agents such as teriparatide, abaloparatide and romosozumab build new bone and are generally reserved for people at very high fracture risk.
- Menopausal hormone therapy protects bone and may suit some younger postmenopausal women, weighed against its other risks.
Treatment is usually reviewed every few years with a repeat DXA scan and reassessment of fracture risk.
Key Takeaways
- Primary osteoporosis is bone loss from aging and menopause, with no other disease or drug to blame.
- Type I follows menopause and mainly affects the spine and wrist. Type II is age-related and prominently affects the hip.
- A T-score of −2.5 or lower on DXA, or a fragility fracture, establishes the diagnosis.
- Secondary causes should always be excluded before labeling osteoporosis primary.
- Calcium, vitamin D, exercise and fall prevention underpin treatment, with medication for those at higher risk.
Frequently Asked Questions
What is the difference between primary and secondary osteoporosis?
Primary osteoporosis results from normal aging and menopause. Secondary osteoporosis is caused by another condition or medication, such as long-term steroids or an overactive parathyroid gland. The distinction matters because secondary causes often need their own treatment.
Can men get primary osteoporosis?
Yes. Men are mainly affected by the age-related (Type II) form, usually later in life than women. Because osteoporosis in men more often has a secondary cause, doctors typically investigate more thoroughly.
Can primary osteoporosis be reversed?
Medication can increase bone density and substantially lower fracture risk, and anabolic drugs actively build new bone. Density rarely returns fully to youthful levels. The realistic goal is to prevent fractures, and treatment does this well.
At what age should I have a bone density scan?
Many guidelines recommend DXA screening for all women aged 65 and older, and earlier for postmenopausal women with risk factors. Screening for men is often considered from around age 70 or earlier if risk factors are present. Your doctor can advise based on your history.
